Diphtheria-Tetanus-Pertussis Vaccine
"Diphtheria-Tetanus-Pertussis Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
| Descriptor ID |
D015721
|
| MeSH Number(s) |
D20.215.894.135.535.300 D20.215.894.691.263.300 D20.215.894.691.824.300 D20.215.894.815.300
|
| Concept/Terms |
Diphtheria-Tetanus-Pertussis Vaccine- Diphtheria-Tetanus-Pertussis Vaccine
- Diphtheria Tetanus Pertussis Vaccine
- Vaccine, Diphtheria-Tetanus-Pertussis
- DTwP Vaccine
- Vaccine, DTwP
- DPT Vaccine
- Vaccine, DPT
- DTP Vaccine
- Vaccine, DTP
- Di-Te-Per Vaccine
- Di Te Per Vaccine
- Vaccine, Di-Te-Per
- Diphtheria-Pertussis-Tetanus Vaccine
- Diphtheria Pertussis Tetanus Vaccine
- Vaccine, Diphtheria-Pertussis-Tetanus
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-Pertussis Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-Pertussis Vaccine".
This graph shows the total number of publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in this website by year, and whether "Diphtheria-Tetanus-Pertussis Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in Profiles.
-
Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy. Vaccine. 2021 08 09; 39(34):4793-4799.
-
Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa. Hum Vaccin Immunother. 2021 06 03; 17(6):1770-1778.
-
Factors associated with missed and delayed DTP3 vaccination in children aged 12 - 59 months in two communities in South Africa, 2012 - 2013. S Afr Med J. 2019 Jul 26; 109(8):562-569.
-
Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration. Hum Vaccin Immunother. 2019; 15(3):658-668.
-
Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines. Expert Rev Vaccines. 2019 01; 18(1):95-104.
-
Hib combination vaccines: efficient and effective. Lancet Infect Dis. 2018 07; 18(7):700-701.
-
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy. Clin Infect Dis. 2017 Nov 13; 65(11):1897-1904.
-
Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014 Feb 20; 28(4):531-41.
-
Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013 Aug; 32(8):889-97.
-
Review of a new fully liquid, hexavalent vaccine: Hexaxim. Expert Opin Biol Ther. 2013 Apr; 13(4):575-93.